meglumine antimonate


Also found in: Encyclopedia.

meglumine antimonate

A drug used in treating leishmaniasis.
See also: meglumine
Mentioned in ?
References in periodicals archive ?
Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimonate.
Clinical efficacy of intramuscular meglumine antimonate alone and in combination with intralezyonel meglumine antimonate in the treatment of old wold cutaneous lesishmaniasis.
Since 1940, the pentavalent antimony compounds sodium stibogluconate and meglumine antimonate have been the mainstays of leishmanial therapy [1,5,10,11].
Standard therapy for all forms of the disease is pentavalent antimony of sodium stibogluconate (Pentostam, GlaxoSmithKline) or meglumine antimonate (Glucantime, Aventis).
The patient's initial treatment included gluteal injections of meglumine antimonate at a dosage of 20 mg antimony/kg/d intramuscularly for a total course of 21 days (LOE=5).
The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis.